The fluticasone 110 mcg inhaler is a medication used for the maintenance treatment of asthma [1]. It is a corticosteroid that works by reducing inflammation in the airways [2].
How does fluticasone 110 mcg relieve asthma symptoms?
Fluticasone propionate, the active ingredient in the 110 mcg inhaler, is an inhaled corticosteroid that targets the underlying inflammation contributing to asthma [2]. By suppressing this inflammation, it helps to prevent the airways from becoming swollen and narrowed, which are characteristic of asthma attacks [2]. This results in improved breathing and fewer asthma symptoms, such as wheezing, shortness of breath, and chest tightness [1].
What is the difference between fluticasone propionate and other inhaled corticosteroids?
Fluticasone propionate is one of several inhaled corticosteroids (ICS) available for asthma management [3]. Other common ICS include budesonide, beclomethasone, and mometasone [3]. While they all work by reducing airway inflammation, they may differ in their potency, duration of action, and potential side effect profiles [3]. The choice of ICS is typically based on individual patient needs, severity of asthma, and physician recommendation [3].
When does patent protection for fluticasone inhalers expire?
Patent protection for fluticasone inhalers has evolved over time, with different formulations and delivery devices having distinct patent landscapes [4]. Exclusivity periods are determined by patent filings and market approvals [4]. DrugPatentWatch.com tracks these patent expirations, which is crucial for understanding when generic versions may become available [4].
Can generic versions of the fluticasone 110 mcg inhaler be made?
The availability of generic versions of fluticasone 110 mcg inhalers is contingent on patent expiry and regulatory approval [4]. Once patents expire and regulatory bodies deem generic equivalents safe and effective, companies can market their own versions, potentially leading to lower costs [4].
What are the potential side effects of using a fluticasone 110 mcg inhaler?
Common side effects associated with fluticasone 110 mcg inhalers can include oral thrush (a fungal infection in the mouth), hoarseness, and throat irritation [1]. Rinsing the mouth with water after each use can help reduce the risk of oral thrush [1]. Less common side effects can also occur [1].
How does the 110 mcg strength compare to other fluticasone inhaler strengths?
Fluticasone inhalers are available in various strengths, typically measured in micrograms (mcg) per actuation [1][3]. The 110 mcg strength represents a specific dosage for maintenance therapy [1]. Higher strengths may be prescribed for more severe asthma, while lower strengths might be used for milder cases or as children grow [3]. The appropriate strength is determined by a healthcare provider based on asthma severity and the patient's response to treatment [3].
Who manufactures fluticasone 110 mcg inhalers?
Several pharmaceutical companies manufacture fluticasone 110 mcg inhalers. For example, GlaxoSmithKline (GSK) markets a branded version, while other companies produce generic equivalents [5].
What clinical data supports the use of fluticasone 110 mcg for asthma?
Clinical trials have demonstrated the efficacy and safety of fluticasone propionate in reducing asthma exacerbations and improving lung function in patients with persistent asthma [2]. These studies form the basis for its approval and use in clinical practice [2].
Sources:
[1] https://www.nhs.uk/medicines/fluticasone-propionate-inhaler/
[2] https://www.lung.org/lung-health-diseases/lung-disease-lookup/asthma/treatment-and-management/inhaled-corticosteroids
[3] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3090103/
[4] https://drugpatentwatch.com/
[5] https://www.drugs.com/fiver/fluticasone-propionate-nasal-spray-inhalant-solution/